LTIMindtree and Eurolife FFH Sign MoU to Setup Gen AI and Digital Hubs in Europe and India
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, today signed a Memorandum of Understanding (MoU) with Eurolife FFH, a leading insurance company in Athens, Greece powered by Fairfax Digital Services, to establish first-of-its-kind Gen AI and Digital Hub in Athens and dedicated facilities in Poland, Europe and Mumbai, India.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220139123/en/
LTIMindtree and Eurolife FFH sign MoU to setup GenAl and digital hubs in India and Europe. In the picture left to right Alexandros Sarrigeorgiou, Chairman & CEO, Eurolife FFH Insurance Group, Sanjay Tugnait, President & Chief Executive Officer, Fairfax Digital Services, Sudhir Chaturvedi, President, and Executive Board Member, LTIMindtree at the residence of Greek Ambassador in Delhi. (Photo: Business Wire)
The MoU was signed by Sudhir Chaturvedi, President and Executive Board Member, LTIMindtree, Alexandros Sarrigeorgiou, Chairman & CEO, Eurolife FFH Insurance Group and Sanjay Tugnait, President & Chief Executive Officer, Fairfax Digital Services, in the presence of Kyriakos Mitsotakis, Prime Minister of Greece at the residence of Greek Ambassador in Delhi. This announcement also aligns with the Government of India’s newly introduced "Anusandhan" scheme, aimed at catalyzing innovation and research within the technology and startup ecosystem.
As a part of this association, Eurolife FFH will set up Generative AI and Digital Hub in Athens to develop innovative solutions for insurance businesses in Greece and LTIMindtree will provide deep domain expertise and support from its dedicated facilities in Poland and Mumbai. Professionals from both the companies will jointly undergo specialized training in Generative AI and Digital Transformation to develop cutting edge products and services that will enhance customer experience and operational efficiency for businesses across insurance, banking, shipping, and manufacturing industries.
Alexandros Sarrigeorgiou, CEO of Eurolife FFH, said, "This partnership is aligned with our ambition of leveraging the power of advanced technology to deliver innovation for our customers and partners. Our goal is to innovate; specifically in the insurance space, and push boundaries to create solutions that meet evolving needs of customers across various other industries. This collaboration is a step towards a future where Gen AI and digital innovation will drive business success and enhance customers’ experience.”
Sudhir Chaturvedi, President and Executive Board Member, LTIMindtree, said, "Our collaboration with Eurolife FFH forms a crucial part of our strategic roadmap, aimed at driving transformative growth for businesses by unlocking the true potential of Gen AI. By merging LTIMindtree’s innovation capabilities with Eurolife FFH’s domain expertise, we are staging a platform for an accelerated adoption of new technologies to address the industry’s most pressing challenges, while establishing new benchmarks in both domestic and international markets.”
Sanjay Tugnait, President, and CEO of Fairfax Digital Services, said, "As Greece and India unite in establishing a Gen AI and Digital Hub, our collaboration transcends borders and algorithms. Together, we engineer a convergence of technological prowess, laying the foundations for creating leading edge industry solutions to enable revenue generation and cost optimization for businesses with a focus on enhancing customer experience. This partnership exemplifies the fusion of diverse cultures and shared visions, which will shape the future landscape of artificial intelligence and digital transformation.”
About LTIMindtree:
LTIMindtree is a global technology consulting and digital solutions company that enables enterprises across industries to reimagine business models, accelerate innovation, and maximize growth by harnessing digital technologies. As a digital transformation partner to more than 700 clients, LTIMindtree brings extensive domain and technology expertise to help drive superior competitive differentiation, customer experiences, and business outcomes in a converging world. Powered by 82,000+ talented and entrepreneurial professionals across more than 30 countries, LTIMindtree — a Larsen & Toubro Group company — combines the industry-acclaimed strengths of erstwhile Larsen and Toubro Infotech and Mindtree in solving the most complex business challenges and delivering transformation at scale. For more information, please visit https://www.ltimindtree.com/.
About Eurolife FFH:
Eurolife FFH aspires to be right by the people, designing insurance products that respond to every need they have. Member of Fairfax Financial Holdings Ltd., it is one of the top organizations in the Greek insurance sector. It offers integrated insurance solutions for individuals and companies that cover every aspect of life and business activity. Eurolife FFH has a broad network of insurance partners all over the country and works with them closely, in order to support its customers so that they can achieve more every day. Eurolife FFH aims to be a catalyst for positive change not only through its insurance products and services, but also through important initiatives that contribute to sustainable development. Having people in the epicentre, it designs and supports purposeful actions that focus on low birth rate and quality of life in remote areas, gender equality and inclusion, culture, entrepreneurship, etc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220139123/en/
Contact information
Media Contact: Shambhavi Revandkar | shambhavi.revandkar@ltimindtree.com
Media Contact: Eleni Lamboura | elamboura@eurolife.gr
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press Release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press Release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom